iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Trading Down 0.1% – What’s Next?

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)’s share price fell 0.1% during mid-day trading on Thursday . The stock traded as low as $21.79 and last traded at $21.90. 86,270 shares changed hands during mid-day trading, an increase of 161% from the average session volume of 33,077 shares. The stock had previously closed at $21.92.

iShares Genomics Immunology and Healthcare ETF Stock Performance

The firm has a 50 day moving average of $23.50 and a 200-day moving average of $24.06. The stock has a market capitalization of $128.12 million, a PE ratio of 2.29 and a beta of 1.14.

Institutional Investors Weigh In On iShares Genomics Immunology and Healthcare ETF

An institutional investor recently bought a new position in iShares Genomics Immunology and Healthcare ETF stock. Avior Wealth Management LLC acquired a new stake in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 9,500 shares of the company’s stock, valued at approximately $234,000. Avior Wealth Management LLC owned approximately 0.16% of iShares Genomics Immunology and Healthcare ETF as of its most recent filing with the Securities & Exchange Commission.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.